deltatrials
Completed EARLY_PHASE1 NCT06139029

Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis

Sponsor: Mardan Medical Complex

Conditions Acute Bronchiolitis
Interventions 3% normal saline steroid(beclomethasone dipropionate 400 μg/day) and salbutamol with 0.9% normal saline
Updated 3 times since 2023 Last updated: Nov 17, 2023 Started: Nov 15, 2022 Primary completion: Mar 15, 2023 Completion: Mar 15, 2023

This EARLY_PHASE1 trial investigates Acute Bronchiolitis and is currently completed. Mardan Medical Complex leads this study, which shows 3 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

3 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed EARLY_PHASE1

  3. Dec 2023 — Jul 2024 [monthly]

    Completed EARLY_PHASE1

    First recorded

Nov 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mardan Medical Complex
Data source: Mardan Medical Complex

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Mardan, Pakistan